House lawmakers approved spending bills on a wide range of cannabis-related policy issues. Provisions on hemp and its derivatives like CBD appeared in a spending bill along with an attached report that covers funding for the USDA and FDA. In the report, lawmakers took issue with the 2018 Farm Bill’s 0.3% THC cap for lawful hemp products and directed USDA to work with HHS and the DEA on a study of whether that threshold is scientifically backed. The committee also flagged another problem hemp industry stakeholders have raised concerning the hemp extraction process. While hemp is defined under federal statute as containing no more than 0.3% THC, those levels can temporarily increase when extracts are being processed, and businesses have expressed concern they may be liable to enforcement action in the interim period because of a lapse in regulatory guidance. The report notes the USDA must work with the DEA to provide direction.